Skip to main content
. Author manuscript; available in PMC: 2010 Jul 8.
Published in final edited form as: Curr Opin Investig Drugs. 2009 Mar;10(3):253–258.

Figure 3. Changes in 14,15-EET concentrations in the plasma with AUDA treatment.

Figure 3

Concentrations of 14,15-epoxyeicosatrienoic acid (14,15-EET) in the coronary venous plasma at 5 and 30 min of reperfusion following treatment with low or high doses of 12-(3-adamantan-1-yl-ureido) dodecanoic acid (AUDA; 0.157 and 0.314 mg/kg, respectively) compared with control values.

*p < 0.01 compared with controls